Despite reporting proof-of-concept results in a mid-stage trial, Kyowa Kirin has decided to discontinue development of its Parkinson's disease candidate KW-6356, a drug in the adenosine A2A receptor ...
6495.T Miyairi Valve Mfg. Co., Ltd.
6327.T Kitagawa Seiki Co.,Ltd.
Stay up to date on how Nippon Gear Co Ltd (6356:XTKS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results